SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : ACRT about to move to new highs -- Ignore unavailable to you. Want to Upgrade?


To: Andrew Q. Viet who wrote (2774)3/9/1998 9:32:00 AM
From: Goulds  Respond to of 7054
 
Mr Aharoni will get compensated with an incentive package. Don't forget, it now has to be approved by the stockholders. Considering that they no longer wish this company to be manipulated by shortsellers, what better way to accomplish this that a buyback. Further, look at the price of ACRT. Itr is less that half of it's true value at the moment. It's damn good business sense to buy the compensation in the form of their own stock as it is such a buy at the moment, and award it to Mr Aharoni the compensation package in a few weeks, when the stock is double what it is now. In effect, the compensation package will cost the company nothing. As a stockholder, I'd certainly have no problem approving this plan.



To: Andrew Q. Viet who wrote (2774)3/9/1998 9:38:00 AM
From: Mr. Pink  Read Replies (3) | Respond to of 7054
 
AMERICAN INDEMNITY CANCELS ACRT INSURANCE

How do you like dem apples?
www3.haaretz.co.il

The Actrade press release was an attempt to address the cancellation of their policy.

Of course the company is "reviewing its overall credit protection practice" It has no insurance coverage.

Self insurance=no insurance. Without insurance, the company company can not get financing.

Dow Chemical contract mentioned on conference call non-existent. More details at the trial.

Goodbye ACRT

Mr. Pink